Trials / Completed
CompletedNCT01046929
Limonene Study in Women With Breast Cancer
Clinical Study of Limonene in Women With a Recent Diagnosis of Early Stage Breast Cancer Electing to Undergo Excision Surgery
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Limonene is a major component in the essential oils of citrus fruits. It has demonstrated promising breast cancer preventive and therapeutic effects in preclinical model systems. This early phase clinical study will evaluate the distribution of limonene to the breast tissue and its associated biological activities after 2 to 6 weeks of limonene dosing in women with a recent diagnosis of early stage breast cancer. This study will help evaluate the potentials of developing limonene as a breast cancer preventive agent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | limonene | oral dosing at 2 gram QD |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-01-12
- Last updated
- 2017-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01046929. Inclusion in this directory is not an endorsement.